<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Genet Mol Biol</journal-id><journal-id journal-id-type="iso-abbrev">Genet. Mol. Biol</journal-id><journal-id journal-id-type="publisher-id">gmb</journal-id><journal-title-group><journal-title>Genetics and Molecular Biology</journal-title></journal-title-group><issn pub-type="ppub">1415-4757</issn><issn pub-type="epub">1678-4685</issn><publisher><publisher-name>Sociedade Brasileira de Gen&#x000e9;tica</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5127148</article-id><article-id pub-id-type="doi">10.1590/1678-4685-GMB-2015-0295</article-id><article-categories><subj-group subj-group-type="heading"><subject>Animal Genetics</subject></subj-group></article-categories><title-group><article-title>Expression of myogenes in <italic>longissimus dorsi</italic> muscle
during prenatal development in commercial and local Piau pigs</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>dos Reis</surname><given-names>Evelyze Pinheiro</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Paix&#x000e3;o</surname><given-names>D&#x000e9;bora Martins</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Brustolini</surname><given-names>Ot&#x000e1;vio Jos&#x000e9; Bernardes</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Silva</surname><given-names>Fabyano Fonseca e</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Silva</surname><given-names>Walmir</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>de Ara&#x000fa;jo</surname><given-names>Fl&#x000e1;vio Marcos Gomes</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Salim</surname><given-names>Anna Christina de Matos</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Oliveira</surname><given-names>Guilherme</given-names></name><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Guimar&#x000e3;es</surname><given-names>Simone Eliza Facioni</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><aff id="aff1"><label>1</label>Departamento de Zootecnia, Universidade Federal de Vi&#x000e7;osa (UFV),
Vi&#x000e7;osa, MG, Brazil</aff><aff id="aff2"><label>2</label>Departamento de Bioqu&#x000ed;mica Agr&#x000ed;cola, Universidade Federal de Vi&#x000e7;osa
(UFV), Vi&#x000e7;osa, MG, Brazil</aff><aff id="aff3"><label>3</label>Fiocruz, Centro de Pesquisas Ren&#x000e9; Rachou, Belo Horizonte, MG,
Brazil</aff><aff id="aff4"><label>4</label>Vale Technology Institute, Bel&#x000e9;m, PA, Brazil</aff></contrib-group><author-notes><corresp>Send correspondence to Evelyze Pinheiro dos Reis. Departamento de Zootecnia,
Universidade Federal de Vi&#x000e7;osa (UFV), Avenida Peter Henry Rolfs, Vi&#x000e7;osa, 36570-000,
MG, Brazil. E-mail: <email>evelyzepinheiro@yahoo.com.br</email></corresp></author-notes><pub-date pub-type="epub"><day>31</day><month>10</month><year>2016</year></pub-date><pub-date pub-type="ppub"><season>Oct-Dec</season><year>2016</year></pub-date><volume>39</volume><issue>4</issue><fpage>589</fpage><lpage>599</lpage><history><date date-type="received"><day>13</day><month>11</month><year>2015</year></date><date date-type="accepted"><day>20</day><month>2</month><year>2016</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2016, Sociedade Brasileira de
Gen&#x000e9;tica.</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>License information: This is an open-access article distributed under the
terms of the Creative Commons Attribution License (type CC-BY), which permits
unrestricted use, distribution and reproduction in any medium, provided the
original article is properly cited.</license-p></license></permissions><abstract><title>Abstract</title><p>This study used qRT-PCR to examine variation in the expression of 13 myogenes during
muscle development in four prenatal periods (21, 40, 70 and 90 days
post-insemination) in commercial (the three-way Duroc, Landrace and Large-White
cross) and local Piau pig breeds that differ in muscle mass. There was no variation
in the expression of the <italic>CHD8, EID2B, HIF1AN, IKBKB, RSPO3, SOX7</italic> and
<italic>SUFU</italic> genes at the various prenatal ages or between breeds. The
<italic>MAP2K1</italic> and <italic>RBM24</italic> genes showed similar expression
between commercial and Piau pigs but greater expression (p &#x0003c; 0.05) in at least one
prenatal period. Pair-wise comparisons of prenatal periods in each breed showed that
only the <italic>CSRP3, LEF1, MRAS</italic> and <italic>MYOG</italic> genes had
higher expression (p &#x0003c; 0.05) in at least one prenatal period in commercial and
Piau pigs. Overall, these results identified the <italic>LEF1</italic> gene as a
primary candidate to account for differences in muscle mass between the pig breeds
since activation of this gene may lead to greater myoblast fusion in the commercial
breed compared to Piau pigs. Such fusion could explain the different muscularity
between breeds in the postnatal periods.</p></abstract><kwd-group><title>Keywords</title><kwd>commercial line</kwd><kwd>gene expression</kwd><kwd>myogenesis</kwd><kwd>pig</kwd><kwd>Piau breed</kwd></kwd-group><counts><fig-count count="3"/><table-count count="5"/><equation-count count="3"/><ref-count count="62"/><page-count count="11"/></counts></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Myogenesis is a prenatal process that involves the formation of muscle fibers through
changes in gene expression and cell phenotype, and is influenced by genetic and
environmental factors (<xref rid="B41" ref-type="bibr">Te Pas <italic>et al.</italic>,
2005</xref>). The size and number of muscle fibers determine muscle mass since
skeletal muscle growth depends on the number of fibers formed during myogenesis and on
postnatal muscle hypertrophy, which is limited by physiological and genetic factors
(<xref rid="B31" ref-type="bibr">Rehfeldt <italic>et al.</italic>, 2000</xref>).</p><p>During prenatal development, two waves of myoblast proliferation and fusion give rise to
primary and secondary muscle fibers (<xref rid="B47" ref-type="bibr">Wigmore and Evans,
2002</xref>). Primary muscle fibers are formed <italic>de novo</italic> in the early
stages of myoblast fusion (first wave of differentiation) and secondary fibers use the
primary fibers as a template in a second wave of differentiation (<xref rid="B31" ref-type="bibr">Rehfeldt <italic>et al.</italic>, 2000</xref>; <xref rid="B41" ref-type="bibr">Te Pas <italic>et al.</italic>, 2005</xref>); the latter fibers account for
the majority of fibers in skeletal muscle (<xref rid="B4" ref-type="bibr">Beermann
<italic>et al.</italic>, 1978</xref>). The number and size of primary myotubes are
intrinsic factors that affect the number of secondary fibers. The number of secondary
myotubes is sensitive to external factors such as nutrition, while the number of primary
myotubes is genetically programmed and is unaffected by exogenous influences (<xref rid="B22" ref-type="bibr">Maltin <italic>et al.</italic>, 2001</xref>). In pigs, the
waves of muscle fiber formation involve relatively long periods of time, i.e., ~30-60
days and 54-90 days of gestation for the first and second waves, respectively (<xref rid="B48" ref-type="bibr">Wigmore and Stickland, 1983</xref>).</p><p>The changes in gene expression associated with muscle development and growth have been
examined in different breeds of pigs at various prenatal ages (<xref rid="B41" ref-type="bibr">Te Pas <italic>et al.</italic>, 2005</xref>; <xref rid="B6" ref-type="bibr">Cagnazzo <italic>et al.</italic>, 2006</xref>; <xref rid="B25" ref-type="bibr">Murani <italic>et al.</italic>, 2007</xref>; <xref rid="B37" ref-type="bibr">Sollero
<italic>et al.</italic>, 2011</xref>; <xref rid="B53" ref-type="bibr">Zhao
<italic>et al.</italic>, 2011</xref>). The analysis of changes in myogenic gene
expression during the prenatal period, when the two waves of myoblast fusion occur, can
be very important for understanding the biochemical differences that contribute to
distinct interbreed variations in the degree of muscularity and meat quality.</p><p>In this study, we analysed the expression of myogenes in a commercial pig line (the
three-way Duroc, Landrace and Large-White cross) and Piau pigs, which differ in
muscularity from the commercial breed, in order to assess possible differences in gene
expression during myogenesis.</p></sec><sec sec-type="materials|methods"><title>Material and Methods</title><sec><title>Biological material</title><p>Embryos and fetuses were obtained by cesarean section from three unrelated pregnant
gilts for each genetic group of pigs (local Piau and commercial breeds) at 21, 40, 70
and 90 days post-insemination (dpi) maintained at the Pig Breeding Farm of the
Departamento de Zootecnia at the Universidade Federal de Vi&#x000e7;osa (UFV). Embryos and
fetuses collected from the commercial breed were obtained from gilts of the three-way
Duroc, Landrace and Large-White cross. Samples from three unrelated fetuses and
embryos were used as biological replicates in gene expression analysis for each breed
at 21, 40, 70 and 90 dpi. The procedures for obtaining the embryos and fetuses were
approved by the Ethics Committee for Animal Use at UFV (protocol no. CEUA-UFV
85/2013), in accordance with current Brazilian federal legislation.</p><p>
<italic>Longissimus dorsi</italic> (LD) muscle was collected at all periods, except
from 21 dpi embryos, for which the whole individual was collected and used in RNA
extraction. Samples were immediately placed in Falconer tubes containing 10 ml of RNA
holder solution (BioAgency Laborat&#x000f3;rios, Brazil) and sent to the Animal Biotechnology
Laboratory at the Departamento de Zootecnia (UFV) where they were stored overnight at
4 &#x000b0;C and then transferred to a freezer at &#x02212;80 &#x000b0;C until RNA extraction.</p></sec><sec><title>RNA extraction</title><p>Total RNA was extracted using TRIzol<sup>&#x000ae;</sup> reagent (Life Technologies, USA).
The RNA was quantified in a NanoVue Plus spectrophotometer (GE Healthcare, Germany)
and RNA A<sub>260</sub>/A<sub>280</sub> ratios of 1.8-2.0 were used as an indicator
of purity. The quality and intactness of extracted RNA were verified by
electrophoresis in a 1% agarose gel. Total RNA was stored at &#x02212;70 &#x000b0;C until cDNA
synthesis.</p></sec><sec><title>cDNA synthesis</title><p>Prior to the reverse transcription step, RNA was treated with DNase I amplification
grade (Invitrogen, USA) to remove contaminant DNA, according to the manufacturer's
instructions. The first strand of complementary DNA (cDNA) was synthesized using a
GoScript<sup>TM</sup> reverse transcription system (Promega, USA), according to
the manufacturer's recommendations. cDNA concentrations were estimated
spectrophotometrically in NanoVue<sup>TM</sup> plus (GE Healthcare) and single
stranded cDNA was stored at &#x02212;20 &#x000b0;C until used in qPCR assays.</p></sec><sec><title>Gene selection and primer design for qRT-PCR</title><p>The genetic data for differentially expressed genes (DEG) from an RNAseq experiment
were used to compare gene expression between breeds in embryos and fetuses of a
commercial pig breed (a two-way Landrace and Large-White cross) and Piau pigs
(unpublished data). HUGO Gene Nomenclature Committee (HGNC) symbols for genes were
obtained with the BIOMART/ENSEMBL program using ENSEMBL transcript identifications
for DEG in conjunction with the pig (<italic>Sus scrofa</italic>) database. When HGNC
symbols were not available for pigs, they were obtained by orthology using the
<italic>Homo sapiens</italic> database. The HGNC symbols for genes were
subsequently subjected to gene ontology analysis.</p><p>Information on gene ontology for the genes was obtained using the ToppCluster program
(<xref rid="B16" ref-type="bibr">Kaimal <italic>et al.</italic>, 2010</xref>). The
terms related to muscle development (myogenesis) were identified and their genes was
used in metabolic pathway analysis. Metabolic pathway maps from KEGG (Kyoto
Encyclopedia of Genes and Genomes) were obtained using DAVID software (<xref rid="B9" ref-type="bibr">Dennis <italic>et al.</italic>, 2003</xref>; <xref rid="B13" ref-type="bibr">Huang <italic>et al.</italic>, 2009</xref>). Cytoscape
software (<xref rid="B36" ref-type="bibr">Shannon <italic>et al.</italic>,
2003</xref>) was used to view and edit the biological processes, molecular
functions and metabolic pathways identified with ToppCluster (<xref rid="B16" ref-type="bibr">Kaimal <italic>et al.</italic>, 2010</xref>) and DAVID (<xref rid="B9" ref-type="bibr">Dennis Jr. <italic>et al.</italic>, 2003</xref>; <xref rid="B13" ref-type="bibr">Huang <italic>et al.</italic>, 2009</xref>) software. In
addition, gene functions were evaluated using a Gene Cards database (<xref rid="B33" ref-type="bibr">Safran <italic>et al.</italic>, 2010</xref>) that
provided concise information on all known and predicted human genes, in addition to
information on gene ontologies that was not obtained by Toppcluster (<xref rid="B16" ref-type="bibr">Kaimal <italic>et al.</italic>, 2010</xref>).</p><p>Based on these findings, 13 genes were selected for analysis of their expression
profiles using RT-qPCR. This work focused on genes that were differentially expressed
between breeds because they represented primary candidates for information on the
source of variation in muscularity and meat quality. The selected genes were related
to myogenesis and were chosen based on gene ontology, the identification of metabolic
pathways and their function.</p><p>qPCR primers were designed using PrimerQuest<sup>&#x000ae;</sup> software (<xref rid="B28" ref-type="bibr">Owczarzy <italic>et al.</italic>, 2008</xref>) and
nucleotide sequences obtained from the <italic>S. scrofa</italic> transcriptome
database at GenBank (<xref rid="B5" ref-type="bibr">Benson <italic>et al.</italic>,
2013</xref>). The only nucleotide sequence not available for pigs was that of
RSPO3, for which a homologous sequence from humans (<italic>Homo sapiens</italic>)
was used. <xref ref-type="table" rid="t1">Table 1</xref> summarizes relevant
information for the genes that were studied, including the accession numbers of the
transcript sequences used in primer design, the nucleotide sequences of the primers
and amplicon size.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><title>GenBank accession numbers, primer sequences and amplicon sizes of the genes
analyzed in this study.</title></caption><table frame="hsides" rules="groups"><colgroup width="25%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000"><tr><th align="left" rowspan="1" colspan="1">Gene</th><th align="center" rowspan="1" colspan="1">Accession number</th><th align="left" rowspan="1" colspan="1">Primer sequences (5&#x02019; &#x02192; 3&#x02019;)</th><th align="center" rowspan="1" colspan="1">Amplicon size<xref ref-type="table-fn" rid="TFN1">1</xref>
</th></tr></thead><tbody style="border-bottom: thin solid; border-color: #000000"><tr><td align="left" rowspan="1" colspan="1">CHD8</td><td align="center" rowspan="1" colspan="1">XM_003482263.1</td><td align="left" rowspan="1" colspan="1">F: AGTGAGGACGAGAAGGAAGA</td><td align="center" rowspan="1" colspan="1">104</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">R: GGGAATCCATCTTGGGACATAG</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">CSRP3</td><td align="center" rowspan="1" colspan="1">NM_001172368.1</td><td align="left" rowspan="1" colspan="1">F: CAGCAACCCTTCCAAGTTCA</td><td align="center" rowspan="1" colspan="1">91</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">R: CATCACCTTCTCAGCAGCATAG</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">EID2B</td><td align="center" rowspan="1" colspan="1">XM_003127131.1</td><td align="left" rowspan="1" colspan="1">F: CGCCACTATCTGGAACACTAC</td><td align="center" rowspan="1" colspan="1">122</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">R: CGCTGATATTCGGCATCAAAC</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">HIF1AN</td><td align="center" rowspan="1" colspan="1">XM_003359328.1</td><td align="left" rowspan="1" colspan="1">F: GTACTGGTGGCATCACATAGAG</td><td align="center" rowspan="1" colspan="1">118</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">R: CTGATGGGCTTTGAGAGGATATT</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">IKBKB</td><td align="center" rowspan="1" colspan="1">NM_001099935.1</td><td align="left" rowspan="1" colspan="1">F: GATGGCGACAGTCAGGAAAT</td><td align="center" rowspan="1" colspan="1">107</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">R: TTGCAAACCACCGTCTTACT</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">LEF1</td><td align="center" rowspan="1" colspan="1">NM_001129967.1</td><td align="left" rowspan="1" colspan="1">F: CTATTGTAACGCCTCAGGTCAA</td><td align="center" rowspan="1" colspan="1">99</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">R: TTGGCTCTTGCTCCTTTCTC</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">MAP2K1</td><td align="center" rowspan="1" colspan="1">NM_001143716.1</td><td align="left" rowspan="1" colspan="1">F: GGAGCTGGAGCTGATGTTT</td><td align="center" rowspan="1" colspan="1">110</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">R: GTCGGCTGTCCATTCCATAA</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">MRAS</td><td align="center" rowspan="1" colspan="1">XM_003358570.2</td><td align="left" rowspan="1" colspan="1">F: GGTCGATTTGATGCATTTGAGG</td><td align="center" rowspan="1" colspan="1">96</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">R: TCCTTGGCACTGGTTTCTATG</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">MYOG</td><td align="center" rowspan="1" colspan="1">NM_001012406.1</td><td align="left" rowspan="1" colspan="1">F: CAGGCTCAAGAAGGTGAATGA</td><td align="center" rowspan="1" colspan="1">118</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">R: GCACTCGATGTACTGGATGG</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">RBM24</td><td align="center" rowspan="1" colspan="1">XM_001925447.3</td><td align="left" rowspan="1" colspan="1">F: TACCTGCCCACTATGTCTATCC</td><td align="center" rowspan="1" colspan="1">118</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">R: GCAGCTCCCGTGTAATCAAT</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">RSPO3</td><td align="center" rowspan="1" colspan="1">NM_032784.4</td><td align="left" rowspan="1" colspan="1">F: GAAACACGGGTCCGAGAAATA</td><td align="center" rowspan="1" colspan="1">110</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">R: CCCTTCTGACACTTCTTCCTTT</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">SOX7</td><td align="center" rowspan="1" colspan="1">XM_003359052.1</td><td align="left" rowspan="1" colspan="1">F: TCTCCACTCCAACCTCCA</td><td align="center" rowspan="1" colspan="1">120</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">R: TCATTGCGATCCATGTCCTC</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">SUFU</td><td align="center" rowspan="1" colspan="1">XM_001928912.4</td><td align="left" rowspan="1" colspan="1">F: GGAGCCCTCATTCCTCTTTG</td><td align="center" rowspan="1" colspan="1">83</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">R: GCCATGTCACCTGTGATACTT</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">ACTB<xref ref-type="table-fn" rid="TFN2">2</xref>
</td><td align="center" rowspan="1" colspan="1">XM_003124280.3</td><td align="left" rowspan="1" colspan="1">F: AAGATCAAGATCATCGCGCCTCCA</td><td align="center" rowspan="1" colspan="1">108</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">R: ACTCCTGCTTGCTGATCCACATCT</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GAPDH<xref ref-type="table-fn" rid="TFN2">2</xref>
</td><td align="center" rowspan="1" colspan="1">NM_001206359.1</td><td align="left" rowspan="1" colspan="1">F: ACAGTCTTCTGGGTGGCAGTGAT</td><td align="center" rowspan="1" colspan="1">176</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">R: CATGTTTGTGATGGGCGTGAACAA</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">HPRT1<xref ref-type="table-fn" rid="TFN2">2</xref>
</td><td align="center" rowspan="1" colspan="1">NM_001032376.2</td><td align="left" rowspan="1" colspan="1">F: GCTGACCTGCTGGATTACAT</td><td align="center" rowspan="1" colspan="1">101</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">R: CTGGTCATTACAGTAGCTCTTCAG</td><td align="center" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>1</label><p>Amplicon size in nucleotide number,</p></fn><fn id="TFN2"><label>2</label><p>Reference gene. CHD8 &#x02013; chromodomain helicase DNA binding protein 8, CSRP3 &#x02013;
cysteine and glycine-rich protein 3, EID2B &#x02013; EP300 interacting inhibitor of
differentiation 2B, HIF1AN &#x02013; hypoxia inducible factor 1, &#x003b1; subunit
inhibitor, IKBKB - inhibitor of &#x003ba; light polypeptide gene enhancer in
B-cells, kinase &#x003b2;, LEF1 &#x02013; lymphoid enhancer-binding factor 1, MAP2K1 &#x02013;
mitogen-activated protein kinase kinase 1, MRAS &#x02013; muscle RAS oncogene
homolog, MYOG &#x02013; myogenin (myogenic factor 4), RBM24 &#x02013; RNA binding motif
protein 24, RSPO3 &#x02013; R-spondin 3, SOX7 &#x02013; SRY (sex determining region Y)-box
7, SUFU &#x02013; suppressor of fused homolog, ACTB &#x02013; &#x003b2;-actin, GAPDH &#x02013;
glyceraldehyde-3-phosphate dehydrogenase, HPRT1 &#x02013; hypoxanthine
phosphoribosyltransferase 1.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Testing of the designed primers</title><p>Primer amplification was assessed with the polymerase chain reaction (PCR) using 75
ng of pooled cDNA derived from embryo and fetal tissues of commercial and Piau pigs.
Primers were tested at 200 nM and an annealing temperature of 60 &#x000b0;C in a
Veriti<sup>&#x000ae;</sup> 96-well thermal cycler (Applied Biosystems, USA). PCR was done
with a GoTaq<sup>&#x000ae;</sup> Green master mix kit (Promega) according to the
manufacturer's protocol. The amplification products were screened for reaction
specificity and the presence of primer dimers by electrophoresis on 8% polyacrylamide
gels at 100 V for 2 h.</p></sec><sec><title>Real time qPCR</title><p>Real time qPCR reactions were run in an ABI Prism 7300 Sequence Detection Systems
thermocycler (Applied Biosystems) using a Gotaq<sup>&#x000ae;</sup> qPCR master mix kit
(Promega) according to the manufacturer's protocol. cDNA (25, 75 or 225 ng) or
nucleic acid-free water (negative control) was added to each well of the plate along
with upstream and downstream primers at 100, 200 or 400 nM.</p><p>The amplification conditions were: 95 &#x000b0;C for 2 min, 40 denaturation cycles at 95 &#x000b0;C
for 15 s, and annealing and extension at 60 &#x000b0;C or 61 &#x000b0;C for 60 s. The efficiency of
amplification was assessed after 40 amplification cycles by including an additional
step in which the temperature was gradually raised from 60 &#x000b0;C to 94 &#x000b0;C to obtain the
primer dissociation curve.</p><p>Target and reference gene amplifications were done in different wells of the same
plate. The assays were run with three biological and two technical replicates for
each treatment in a single 96-well plate. The coefficient of variation, used as an
indicator of precision and reproducibility, was less than 5%, which was adequate for
the Ct (threshold cycle) values of the technical replicates within each sample.</p></sec><sec><title>Amplification efficiency</title><p>To calculate the amplification efficiency of target and reference genes, all
reactions were done in 96-well plates using pooled cDNAs containing biological
replicates of treatments and two technical replicates for each treatment. From the
real time qPCR raw data, the Ct values and log<sub>10</sub> amount of cDNA (25, 75
and 225 ng) were plotted in graphs for primers at 100, 200 and 400 nM. The slope of
the resulting relationship was determined by linear regression and was used to
calculate the amplification efficiency with the following equation, modified from
<xref rid="B30" ref-type="bibr">Rasmussen (2001)</xref>, in which efficiencies
equal to 1 represent 100%:</p><disp-formula id="e1"><mml:math id="m1"><mml:mrow><mml:mi mathvariant="normal">E</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mtext>slope</mml:mtext></mml:mrow></mml:mfrac></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msup><mml:mo>&#x02212;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></disp-formula><p>Based on the results obtained in the preceding step, the highest amplification
efficiency of target and reference genes was chosen, along with the appropriate
primer concentration and quantity of cDNA for each gene to be used in the final qPCR
reactions. Amplification efficiencies of 0.80 to 1.0 were considered appropriate
(<inline-supplementary-material mime-subtype="pdf" mimetype="application" xlink:href="1415-4757-gmb-1678-4685-GMB-2015-0295-Suppl01.pdf" id="d35e823" content-type="local-data">Table
S1</inline-supplementary-material>). The suitability of three reference genes
(ACTB, GAPDH and HPRT1) for qRT-PCR was investigated using NormFinder software (<xref rid="B1" ref-type="bibr">Andersen <italic>et al.</italic>, 2004</xref>), and GAPDH
was selected for data normalization since the gene used for this procedure should
show no change in expression along the treatments. Ct values for a specific gene were
normalized to the Ct value of highest expression (Ct minimum value) for that gene.
The normalized Ct values were then used in the following equation (<xref rid="B23" ref-type="bibr">McCulloch <italic>et al.</italic>, 2012</xref>):</p><disp-formula id="e2"><mml:math id="m2"><mml:mrow><mml:mi mathvariant="normal">Q</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mi mathvariant="normal">E</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mtext>min Ct</mml:mtext><mml:mo>&#x02013;</mml:mo><mml:mtext>Ct sample</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula><p>where: Q = normalized Ct value for a gene in the current sample, E = calculated
amplification efficiency (ranging from 1 to 2, in which 100% = 2), min Ct = minimum
Ct value for a gene among all samples, and Ct sample = Ct value for current sample
and gene.</p></sec><sec><title>Statistical analysis</title><p>The experimental design was a completely randomized 2 (breeds) x 4 (prenatal ages)
factorial design with six repetitions (three biological and two technical replicates)
per treatment. ANOVA was done using the following statistical model:</p><disp-formula id="e3"><mml:math id="m3"><mml:mrow><mml:msub><mml:mi mathvariant="normal">Y</mml:mi><mml:mrow><mml:mtext>ijkl</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mtext>&#x003bc;</mml:mtext><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">A</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mtext>ij</mml:mtext><mml:mo stretchy="false">)</mml:mo><mml:mi mathvariant="normal">I</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">D</mml:mi><mml:mrow><mml:mtext>ijk</mml:mtext></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mtext>RIG</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mtext>ijk</mml:mtext></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mtext>&#x003b5;</mml:mtext><mml:mrow><mml:mtext>ijkl</mml:mtext></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mtext> where</mml:mtext></mml:mrow></mml:math></disp-formula><p>Y<sub>ijkl</sub> is the expression level of gene k, in animal l, breed i and prenatal
age j, in which i = 1 or 2 (commercial or Piau breed, respectively) and j = 1, 2, 3
or 4 (21, 40, 70 or 90 dpi, respectively),</p><p>&#x003bc; is the general constant,</p><p>A<sub>(ij)l</sub> is the random effect of animal l in breed i and age j,</p><p>A<sub>(ij)l</sub> ~ N(0, &#x003c3;<sup>2</sup>
<sub>A</sub>),</p><p>D<sub>ijk</sub> is the sample-specific random effect (common to both genes),
D<sub>ijk</sub> ~ N(0, &#x003c3;<sup>2</sup>
<sub>D</sub>),</p><p>(RIG)<sub>ijk</sub> is the interaction effect between breed i and age j in gene k,
and</p><p>&#x003b5;<sub>ijkl</sub> is the random error, i.e., &#x003b5;<sub>ijkl</sub> ~ N(0, &#x003c3;<sup>2</sup>
<sub>e</sub>).</p><p>This model was fitted to the data using the %QPCR_MIXED macro in SAS (Statistical
Analysis System Institute Inc., USA), which is based on linear mixed models (<xref rid="B38" ref-type="bibr">Steibel <italic>et al.</italic>, 2009</xref>). The
significance of contrast estimate values was assessed using Student's
<italic>t</italic>-test. Contrast estimate values correspond to &#x00394;&#x00394;Ct and were used
to assess relative expression (fold-change) by using the formula 2<sup>&#x02013;&#x00394;&#x00394;Ct</sup>
(<xref rid="B21" ref-type="bibr">Livak and Schmittgen, 2001</xref>). In all cases,
the level of significance was set at p &#x0003c; 0.05.</p></sec></sec><sec sec-type="results"><title>Results</title><p>To understand the role of the 13 selected genes, information on gene ontology was
obtained using Toppcluster software and metabolic pathways were investigated using DAVID
software. These 13 genes are part of relevant functional metabolic networks for muscle
development (<xref ref-type="fig" rid="f1">Figure 1</xref>). These networks are for
skeletal muscle contraction, muscle structure development, embryo development, organ
development, muscle organ development, muscle differentiation, contractile fiber,
musculoskeletal movement, muscle system process, and HEDGEHOG, MAPK and WNT signaling
pathways. In addition, <xref ref-type="table" rid="t2">Table 2</xref> describes the
function of these 13 genes as defined in gene ontology terms.</p><fig id="f1" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Functional gene networks and their interactions, showing the relationship
between 13 genes (green). Twelve important subnets related to muscle development
were included in biological process (pink), molecular function (violet) and
metabolic pathway (yellow).</title></caption><graphic xlink:href="1415-4757-gmb-1678-4685-GMB-2015-0295-gf01"/></fig><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Metabolic pathways and gene ontologies for genes represented in the gene
network.</title></caption><table frame="hsides" rules="groups"><colgroup width="20%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000"><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"/><th align="center" colspan="3" style="border-bottom: thin solid; border-color: #000000" valign="bottom" rowspan="1">Gene ontologies</th></tr><tr><th align="left" rowspan="1" colspan="1">Gene</th><th align="left" rowspan="1" colspan="1">Metabolic pathway</th><th align="left" rowspan="1" colspan="1">Cellular component</th><th align="left" rowspan="1" colspan="1">Molecular function</th><th align="left" rowspan="1" colspan="1">Biological process</th></tr></thead><tbody style="border-bottom: thin solid; border-color: #000000"><tr><td align="left" rowspan="1" colspan="1">CHD8</td><td align="left" rowspan="1" colspan="1">WNT signaling pathway</td><td align="left" rowspan="1" colspan="1">Nuclear lumen</td><td align="left" rowspan="1" colspan="1">Histone and DNA binding</td><td align="left" rowspan="1" colspan="1">Embryo development</td></tr><tr><td align="left" rowspan="1" colspan="1">CSRP3</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">Cytoskeleton</td><td align="left" rowspan="1" colspan="1">Contractile fiber</td><td align="left" rowspan="1" colspan="1">Muscle organ development/Muscle
structure development/Muscle system process</td></tr><tr><td align="left" rowspan="1" colspan="1">EID2B</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">Nucleus</td><td align="left" rowspan="1" colspan="1">Muscle differentiation</td><td align="left" rowspan="1" colspan="1">Muscle organ development</td></tr><tr><td align="left" rowspan="1" colspan="1">HIF1AN</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">Nucleus/cytosol</td><td align="left" rowspan="1" colspan="1">Protein binding</td><td align="left" rowspan="1" colspan="1">Muscle organ development/Muscle
structure development</td></tr><tr><td align="left" rowspan="1" colspan="1">IKBKB</td><td align="left" rowspan="1" colspan="1">MAPK signaling pathway</td><td align="left" rowspan="1" colspan="1">Nucleus/cytosol</td><td align="left" rowspan="1" colspan="1">Protein binding</td><td align="left" rowspan="1" colspan="1">Muscle system process/Musculoskeletal
movement/Skeletal muscle contraction</td></tr><tr><td align="left" rowspan="1" colspan="1">LEF1</td><td align="left" rowspan="1" colspan="1">WNT signaling pathway</td><td align="left" rowspan="1" colspan="1">Nucleus</td><td align="left" rowspan="1" colspan="1">Chromatin and DNA binding</td><td align="left" rowspan="1" colspan="1">Embryo development</td></tr><tr><td align="left" rowspan="1" colspan="1">MAP2K1</td><td align="left" rowspan="1" colspan="1">MAPK signaling pathway</td><td align="left" rowspan="1" colspan="1">Cytoskeleton/cytosol/nucleus</td><td align="left" rowspan="1" colspan="1">Protein kinase activity</td><td align="left" rowspan="1" colspan="1">Muscle system process</td></tr><tr><td align="left" rowspan="1" colspan="1">MRAS</td><td align="left" rowspan="1" colspan="1">MAPK signaling pathway</td><td align="left" rowspan="1" colspan="1">Intracellular</td><td align="left" rowspan="1" colspan="1">GTPase activity/nucleotide
binding</td><td align="left" rowspan="1" colspan="1">Muscle organ development/Organ
development</td></tr><tr><td align="left" rowspan="1" colspan="1">MYOG</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">Nucleus</td><td align="left" rowspan="1" colspan="1">Chromatin and DNA binding</td><td align="left" rowspan="1" colspan="1">Muscle organ development/Muscle
structure development</td></tr><tr><td align="left" rowspan="1" colspan="1">RBM24</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">Nucleus/cytoplasm</td><td align="left" rowspan="1" colspan="1">Nucleotide binding</td><td align="left" rowspan="1" colspan="1">Muscle organ development/Organ
development</td></tr><tr><td align="left" rowspan="1" colspan="1">RSPO3</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">Extracellular region</td><td align="left" rowspan="1" colspan="1">Receptor binding</td><td align="left" rowspan="1" colspan="1">Embryo development</td></tr><tr><td align="left" rowspan="1" colspan="1">SOX7</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">Nucleus/cytoplasm</td><td align="left" rowspan="1" colspan="1">Nucleic acid binding</td><td align="left" rowspan="1" colspan="1">Embryo development</td></tr><tr><td align="left" rowspan="1" colspan="1">SUFU</td><td align="left" rowspan="1" colspan="1">Hedgehog signaling pathway</td><td align="left" rowspan="1" colspan="1">Nucleus/cytoplasm</td><td align="left" rowspan="1" colspan="1">Transcription corepressor
activity</td><td align="left" rowspan="1" colspan="1">Embryo development/Organ
development</td></tr></tbody></table></table-wrap><p>qRT-PCR assays were done at four prenatal ages (21, 40, 70 and 90 dpi) in commercial and
Piau pigs and the data were analyzed using ANOVA (<xref ref-type="table" rid="t3">Table
3</xref>). Seven genes (<italic>CHD8, EID2B, HIF1AN, IKBKB, RSPO3, SOX7</italic> and
<italic>SUFU</italic>) showed no significant alterations, indicating that their
expression was constant over time and between breeds. Two genes (<italic>MAP2K1</italic>
and <italic>RBM24</italic>) showed significant changes (p &#x0003c; 0.05) in relation to the
prenatal period, but there was no significant Breed x Period interaction for these
genes. <xref ref-type="table" rid="t4">Table 4</xref> shows the Student's
<italic>t</italic>-test results for pair-wise comparisons among the prenatal periods
for these genes. The relative gene expression (fold-change) for pair-wise comparisons of
prenatal periods is shown in <xref ref-type="fig" rid="f2">Figure 2</xref>. Of the genes
analyzed, <italic>MAP2K1</italic> showed greater expression at 40 dpi (period of primary
fiber formation) and 70 dpi (period of secondary fiber formation), whereas
<italic>RBM24</italic> showed greater expression at 40 dpi (period of primary fiber
formation) and at 70 and 90 dpi (periods of secondary fiber formation).</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><title>P-values for ANOVA in relation to Breed, Period and interaction Breed x Period
for the genes studied.</title></caption><table frame="hsides" rules="groups"><colgroup width="25%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000"><tr><th align="left" rowspan="2" valign="top" colspan="1">Genes</th><th align="center" colspan="3" style="border-bottom: thin solid; border-color: #000000" rowspan="1">Factors</th></tr><tr><th align="center" rowspan="1" colspan="1">Breed</th><th align="center" rowspan="1" colspan="1">Period</th><th align="center" rowspan="1" colspan="1">Breed x Period</th></tr></thead><tbody style="border-bottom: thin solid; border-color: #000000"><tr><td align="left" rowspan="1" colspan="1">CHD8</td><td align="center" rowspan="1" colspan="1">0.9764</td><td align="center" rowspan="1" colspan="1">0.3615</td><td align="center" rowspan="1" colspan="1">0.6094</td></tr><tr><td align="left" rowspan="1" colspan="1">CSRP3</td><td align="center" rowspan="1" colspan="1">0.8615</td><td align="center" rowspan="1" colspan="1">
<bold>&#x0003c; 0.0001</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>&#x0003c; 0.0001</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">EID2B</td><td align="center" rowspan="1" colspan="1">0.9072</td><td align="center" rowspan="1" colspan="1">0.1615</td><td align="center" rowspan="1" colspan="1">0.4284</td></tr><tr><td align="left" rowspan="1" colspan="1">HIF1AN</td><td align="center" rowspan="1" colspan="1">0.5757</td><td align="center" rowspan="1" colspan="1">0.2535</td><td align="center" rowspan="1" colspan="1">0.5533</td></tr><tr><td align="left" rowspan="1" colspan="1">IKBKB</td><td align="center" rowspan="1" colspan="1">0.7473</td><td align="center" rowspan="1" colspan="1">0.6656</td><td align="center" rowspan="1" colspan="1">0.6948</td></tr><tr><td align="left" rowspan="1" colspan="1">LEF1</td><td align="center" rowspan="1" colspan="1">0.9772</td><td align="center" rowspan="1" colspan="1">
<bold>&#x0003c; 0.0001</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>0.0004</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">MAP2K1</td><td align="center" rowspan="1" colspan="1">0.4445</td><td align="center" rowspan="1" colspan="1">
<bold>0.0125</bold>
</td><td align="center" rowspan="1" colspan="1">0.0712</td></tr><tr><td align="left" rowspan="1" colspan="1">MRAS</td><td align="center" rowspan="1" colspan="1">0.6557</td><td align="center" rowspan="1" colspan="1">
<bold>0.0019</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>0.0205</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">MYOG</td><td align="center" rowspan="1" colspan="1">0.7314</td><td align="center" rowspan="1" colspan="1">
<bold>&#x0003c; 0.0001</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>&#x0003c; 0.0001</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">RBM24</td><td align="center" rowspan="1" colspan="1">0.9866</td><td align="center" rowspan="1" colspan="1">
<bold>0.0284</bold>
</td><td align="center" rowspan="1" colspan="1">0.1756</td></tr><tr><td align="left" rowspan="1" colspan="1">RSPO3</td><td align="center" rowspan="1" colspan="1">0.7198</td><td align="center" rowspan="1" colspan="1">0.0885</td><td align="center" rowspan="1" colspan="1">0.2230</td></tr><tr><td align="left" rowspan="1" colspan="1">SOX7</td><td align="center" rowspan="1" colspan="1">0.3451</td><td align="center" rowspan="1" colspan="1">0.4870</td><td align="center" rowspan="1" colspan="1">0.6915</td></tr><tr><td align="left" rowspan="1" colspan="1">SUFU</td><td align="center" rowspan="1" colspan="1">0.6504</td><td align="center" rowspan="1" colspan="1">0.2974</td><td align="center" rowspan="1" colspan="1">0.4175</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><p>Values in bold were statistically significant (p &#x0003c; 0.05) by F-Test;</p></fn></table-wrap-foot></table-wrap><table-wrap id="t4" orientation="portrait" position="float"><label>Table 4</label><caption><title>P-values for two-period comparisons for the genes MAP2K1 and RBM24. The ANOVA
results (F-test) for these genes were significant for the factor Period.</title></caption><table frame="hsides" rules="groups"><colgroup width="14%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000"><tr><th align="left" rowspan="2" valign="bottom" colspan="1">Genes</th><th align="center" colspan="6" style="border-bottom: thin solid; border-color: #000000" rowspan="1">Comparisons</th></tr><tr><th align="center" rowspan="1" colspan="1">21d x 40d<xref ref-type="table-fn" rid="TFN4">
<sup>a</sup>
</xref>
</th><th align="center" rowspan="1" colspan="1">21d x 70d</th><th align="center" rowspan="1" colspan="1">21d x 90d</th><th align="center" rowspan="1" colspan="1">40d x 70d</th><th align="center" rowspan="1" colspan="1">40d x 90d</th><th align="center" rowspan="1" colspan="1">70d x 90d</th></tr></thead><tbody style="border-bottom: thin solid; border-color: #000000"><tr><td align="left" rowspan="1" colspan="1">MAP2K1</td><td align="center" rowspan="1" colspan="1">
<bold>0.0027</bold>
</td><td align="center" rowspan="1" colspan="1">0.0772</td><td align="center" rowspan="1" colspan="1">0.1882</td><td align="center" rowspan="1" colspan="1">0.1177</td><td align="center" rowspan="1" colspan="1">
<bold>0.0456</bold>
</td><td align="center" rowspan="1" colspan="1">0.6143</td></tr><tr><td align="left" rowspan="1" colspan="1">RBM24</td><td align="center" rowspan="1" colspan="1">
<bold>0.0192</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>0.0165</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>0.0188</bold>
</td><td align="center" rowspan="1" colspan="1">0.9412</td><td align="center" rowspan="1" colspan="1">0.9917</td><td align="center" rowspan="1" colspan="1">0.9495</td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><label>a</label><p>21d, 40d, 70d and 90d indicate the prenatal ages. Values in bold were
statistically significant (p &#x0003c; 0.05).</p></fn></table-wrap-foot></table-wrap><fig id="f2" orientation="portrait" position="float"><label>Figure 2</label><caption><title>Relative expression levels for two genes (MAP2K1 and RMB24) in pair-wise
comparisons of prenatal ages (21, 40, 70 and 90 days post-insemination). These
genes differed significantly in relation to the factor &#x02018;Period&#x02019; (p &#x0003c; 0.05,
F-test in ANOVA), but showed no significant difference for the interaction &#x02018;Breed
x Period&#x02019;. *p &#x0003c; 0.05 and **p &#x0003c; 0.01 indicates significant pair-wise
comparisons by Student's <italic>t</italic>-test. A positive fold-change means
that the first period in the comparison shows greater expression than the second
period. Negative fold-change means that the second period in comparison presents
greater expression than the first period.</title></caption><graphic xlink:href="1415-4757-gmb-1678-4685-GMB-2015-0295-gf02"/></fig><p>Four genes (<italic>CSRP3, MRAS, LEF1</italic> and <italic>MYOG</italic>) showed a
significant (p &#x0003c; 0.05) Breed x Period interaction and Period factor based on ANOVA.
<xref ref-type="table" rid="t5">Table 5</xref> shows the Student's
<italic>t</italic>-test results for comparisons that assessed a Breed x Period
interaction for these genes. The relative gene expression (fold-change) for pair-wise
comparisons of prenatal periods is shown in <xref ref-type="fig" rid="f3">Figure
3</xref> and revealed Breed x Period interactions (p &#x0003c; 0.05).</p><table-wrap id="t5" orientation="portrait" position="float"><label>Table 5</label><caption><title>P-values for two-period comparisons in commercial and Piau pigs. The ANOVA
results (F-test) for these genes showed a significant Breed x Period
interaction.</title></caption><table frame="hsides" rules="groups"><colgroup width="12%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000"><tr><th align="left" rowspan="2" valign="bottom" colspan="1">Genes</th><th align="center" rowspan="2" valign="bottom" colspan="1">Breed</th><th align="center" colspan="6" style="border-bottom: thin solid; border-color: #000000" rowspan="1">Comparisons</th></tr><tr><th align="center" rowspan="1" colspan="1">21d x 40d<xref ref-type="table-fn" rid="TFN5">
<sup>a</sup>
</xref>
</th><th align="center" rowspan="1" colspan="1">21d x 70d</th><th align="center" rowspan="1" colspan="1">21d x 90d</th><th align="center" rowspan="1" colspan="1">40d x 70d</th><th align="center" rowspan="1" colspan="1">40d x 90d</th><th align="center" rowspan="1" colspan="1">70d x 90d</th></tr></thead><tbody style="border-bottom: thin solid; border-color: #000000"><tr><td align="left" rowspan="1" colspan="1">CSRP3</td><td align="center" rowspan="1" colspan="1">Commercial</td><td align="center" rowspan="1" colspan="1">
<bold>0.0032</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>0.0003</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>0.0003</bold>
</td><td align="center" rowspan="1" colspan="1">0.2524</td><td align="center" rowspan="1" colspan="1">0.3070</td><td align="center" rowspan="1" colspan="1">0.8964</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Piau</td><td align="center" rowspan="1" colspan="1">
<bold>0.0309</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>0.0029</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>0.0035</bold>
</td><td align="center" rowspan="1" colspan="1">0.2719</td><td align="center" rowspan="1" colspan="1">0.3062</td><td align="center" rowspan="1" colspan="1">0.9365</td></tr><tr><td align="left" rowspan="1" colspan="1">LEF1</td><td align="center" rowspan="1" colspan="1">Commercial</td><td align="center" rowspan="1" colspan="1">0.5880</td><td align="center" rowspan="1" colspan="1">
<bold>0.0049</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>0.0058</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>0.0155</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>0.0183</bold>
</td><td align="center" rowspan="1" colspan="1">0.9356</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Piau</td><td align="center" rowspan="1" colspan="1">
<bold>0.0257</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>0.0045</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>0.0007</bold>
</td><td align="center" rowspan="1" colspan="1">0.4091</td><td align="center" rowspan="1" colspan="1">0.1052</td><td align="center" rowspan="1" colspan="1">0.3973</td></tr><tr><td align="left" rowspan="1" colspan="1">MRAS</td><td align="center" rowspan="1" colspan="1">Commercial</td><td align="center" rowspan="1" colspan="1">0.0575</td><td align="center" rowspan="1" colspan="1">0.8639</td><td align="center" rowspan="1" colspan="1">0.3663</td><td align="center" rowspan="1" colspan="1">
<bold>0.0412</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>0.0089</bold>
</td><td align="center" rowspan="1" colspan="1">0.4609</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Piau</td><td align="center" rowspan="1" colspan="1">0.1992</td><td align="center" rowspan="1" colspan="1">0.3261</td><td align="center" rowspan="1" colspan="1">0.1414</td><td align="center" rowspan="1" colspan="1">
<bold>0.0318</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>0.0107</bold>
</td><td align="center" rowspan="1" colspan="1">0.6007</td></tr><tr><td align="left" rowspan="1" colspan="1">MYOG</td><td align="center" rowspan="1" colspan="1">Commercial</td><td align="center" rowspan="1" colspan="1">
<bold>0.0026</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>0.0002</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>0.0012</bold>
</td><td align="center" rowspan="1" colspan="1">0.2565</td><td align="center" rowspan="1" colspan="1">0.7099</td><td align="center" rowspan="1" colspan="1">0.4366</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Piau</td><td align="center" rowspan="1" colspan="1">
<bold>0.0001</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>0.0006</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>0.0004</bold>
</td><td align="center" rowspan="1" colspan="1">0.4341</td><td align="center" rowspan="1" colspan="1">0.5396</td><td align="center" rowspan="1" colspan="1">0.8629</td></tr></tbody></table><table-wrap-foot><fn id="TFN5"><label>a</label><p>21d, 40d, 70d and 90d indicate the prenatal ages. Values in bold were
statistically significant (p &#x0003c; 0.05) by Student's
<italic>t</italic>-test.</p></fn></table-wrap-foot></table-wrap><fig id="f3" orientation="portrait" position="float"><label>Figure 3</label><caption><title>Relative expression for four genes (CSRP3, LEF1, MRAS and MYOG) in pair-wise
comparisons of prenatal ages (21, 40, 70 and 90 days post-insemination) in
commercial and Piau pigs. These genes showed a significant interaction for Breed x
Period (p &#x0003c; 0.05, F-test in ANOVA). *p &#x0003c; 0.05 and **p &#x0003c; 0.01 indicates
significant pair-wise comparisons by Student's <italic>t</italic>-test. A positive
fold-change means that the first period in the comparison shows greater expression
than the second period. Negative fold-change means that the second period in the
comparison presents greater expression than the first period.</title></caption><graphic xlink:href="1415-4757-gmb-1678-4685-GMB-2015-0295-gf03"/></fig><p>
<xref ref-type="fig" rid="f3">Figure 3</xref> and <xref ref-type="table" rid="t5">Table
5</xref> show that commercial and Piau pigs had similar expression patterns for
<italic>CSRP3, MRAS</italic> and <italic>MYOG. CSRP3</italic> showed greater
expression during the two waves of myoblast fusion that gave rise to primary fibers at
40 dpi and secondary fibers at 70 and 90 dpi. <italic>MRAS</italic> showed greater
expression during somite formation and proliferation at 21 dpi and during primary fiber
formation at 40 dpi. <italic>MYOG</italic> had a greater expression at 40 dpi (period of
primary fiber formation) and at 70 and 90 dpi (period of secondary fiber formation).
<italic>LEF1</italic> showed a divergent expression pattern for commercial and Piau
pigs: expression was greater at 21 dpi (period of somite formation and proliferation)
and 40 dpi (period of primary fiber formation) in commercial pigs, whereas in Piau pigs
this gene showed greater expression only at 21 dpi.</p></sec><sec sec-type="discussion"><title>Discussion</title><p>Thirteen genes related to important gene networks for muscle development and structure
were analyzed by qRT-PCR to determine their expression profiles at 21 dpi (embryos) and
at 40, 70 and 90 dpi (fetuses) in commercial (three-way Duroc, Landrace and Large-White
cross) and local Piau pigs. In 21 dpi embryos we examined the region that would give
rise to muscle, and which should contain only undifferentiated mesenchymal stem cells
(also known as somite cells), since a histochemical study of pig embryos at 20 dpi found
only somites in this region (<xref rid="B39" ref-type="bibr">Swatland and Cassens,
1973</xref>). In the other periods analyzed, primary myotubes were formed at 40 dpi
and secondary myotubes developed at 70 and 90 dpi after myoblast differentiation. The
analysis of myogene expression in these periods shed light on possible differences in
myogenesis and subsequent muscularity in commercial and Piau pigs. Local Piau pigs are
expected to have a higher level of fat than commercial pigs (<xref rid="B35" ref-type="bibr">Serao <italic>et al.</italic>, 2011</xref>), which have a greater muscle
mass.</p><p>Muscle mass is influenced by the number and size of its muscle fibers (<xref rid="B31" ref-type="bibr">Rehfeldt <italic>et al.</italic>, 2000</xref>). We
therefore focused on the expression of genes involved in the formation of myogenic cells
in four periods since differential gene expression between genetically distinct lineages
and periods could explain differences in muscle mass between breeds. Muscle development
is a complex biological process regulated by various genes that interact with each other
and a series of signal transduction pathways (<xref rid="B53" ref-type="bibr">Zhao
<italic>et al.</italic>, 2011</xref>). Myogenic regulatory factors are controlled
by regulatory pathways that activate or repress their activity, although additional
factors are also probably involved in various transcription circuits that control
myogenesis (<xref rid="B18" ref-type="bibr">Kong <italic>et al.</italic>,
1997</xref>).</p><p>
<italic>MAP2K1</italic> showed similar expression in both breeds, with greater
expression during primary and secondary fiber formation (40 and 70 dpi, respectively).
This gene is involved in the MAPK signaling pathway that is important for muscle
development since it can activate transcription factors involved in differentiation
(<xref rid="B17" ref-type="bibr">Keren <italic>et al.</italic>, 2006</xref>), such as
MEF2A, MEF2C and MYOD (<xref rid="B50" ref-type="bibr">Wu <italic>et al.</italic>,
2000</xref>) that can accelerate myoblast differentiation (<xref rid="B43" ref-type="bibr">Ulloa <italic>et al.</italic>, 2007</xref>). MAP2K1 can inhibit and
activate myogenesis, depending on the developmental stage (<xref rid="B15" ref-type="bibr">Jo <italic>et al.</italic>, 2009</xref>), and can negatively control the
switch from myoblast proliferation to differentiation by suppressing MYOD activity in
the early stages of myogenesis (<xref rid="B29" ref-type="bibr">Perry <italic>et
al.</italic>, 2001</xref>). In contrast, the presence of MAP2K1 protein in the
nucleus of proliferating myoblasts can have a stimulatory role on muscle differentiation
(<xref rid="B15" ref-type="bibr">Jo <italic>et al.</italic>, 2009</xref>). Thus, the
differential expression at 40 dpi and 70 dpi suggests that MAP2K1 may have a stimulatory
role in myoblast differentiation in myotubes of both breeds.</p><p>
<italic>RBM24</italic> showed a similar expression pattern in commercial and Piau pigs,
with greater expression during primary and secondary fiber formation (at 40 dpi and
70-90 dpi, respectively). <italic>RBM24</italic> is involved in biological processes
related to muscle organ development. RBM24 protein interacts with <italic>MYOG</italic>
mRNA to regulate the stability and expression of the latter through a
post-transcriptional regulatory pathway (<xref rid="B14" ref-type="bibr">Jin <italic>et
al.</italic>, 2010</xref>), but can also promote myogenic differentiation by
modulating the cell cycle (<xref rid="B24" ref-type="bibr">Miyamoto <italic>et
al.</italic>, 2009</xref>). The <italic>RBM24</italic> expression profile
confirmed its role in controlling the stability and expression of <italic>MYOG</italic>
mRNA and may therefore be involved in promoting primary and secondary fiber formation in
both breeds. <italic>MYOG</italic> expression was also evaluated and showed a similar
level of expression to <italic>RBM24</italic> throughout prenatal periods, as described
below.</p><p>
<italic>MYOG</italic> showed greater expression during the periods of primary (40 dpi)
and secondary (70 dpi and 90 dpi) fiber formation in commercial and Piau pigs. This gene
is related to the biological processes of muscle structure development and muscle organ
development. MYOG is an important myogenic regulatory factor that is necessary for the
formation of multinucleated myotubes (<xref rid="B17" ref-type="bibr">Keren <italic>et
al.</italic>, 2006</xref>). These results confirmed the importance of this
transcription factor for primary and secondary fiber formation during myogenic
differentiation and showed that <italic>MYOG</italic> mRNA can be stabilized by RBM24
proteins since the synthesis of this mRNA is also high during primary and secondary
fiber formation.</p><p>
<italic>CSRP3</italic> showed greater expression during primary fiber (40 dpi) and
secondary fiber (70 and 90 dpi) formation in commercial and Piau pigs. This gene is
included in the molecular function of contractile fiber and in the biological processes
of muscle system process, muscle organ development and muscle structure development.
CSRP3 promotes myoblast differentiation and it is first expressed and accumulated in the
nucleus when there is myotube formation and growth (<xref rid="B2" ref-type="bibr">Arber
<italic>et al.</italic>, 1994</xref>). As shown here, <italic>CSRP3</italic>
expression was enhanced during the two waves of myoblast differentiation in both breeds,
in agreement with its role in primary and secondary fiber formation.</p><p>
<italic>LEF1</italic> showed greater expression at 21 dpi and 40 dpi in commercial and
at 21 dpi in Piau pigs, with lower expression thereafter. This gene belongs to the WNT
signaling pathway and is related to the biological process of embryo development. The
WNT pathway is important for muscle development because it can control the expression of
myogenic regulatory factors such as MYF5 and MYOD, thereby influencing myogenic
differentiation and survival (<xref rid="B8" ref-type="bibr">Cossu and Borello,
1999</xref>; <xref rid="B44" ref-type="bibr">von Maltzahn <italic>et al.</italic>,
2012</xref>). LEF1 can induce cellular cycle progression, cellular differentiation
and apoptosis through transcriptional activation of <italic>E2F1</italic> (<xref rid="B54" ref-type="bibr">Zhou <italic>et al.</italic>, 2008</xref>). Based on the
expression profile observed here, LEF1 is more important in the early stages of muscle
development, mainly at 21 dpi when somites are formed and proliferate. The additional
peak of expression seen at 40 dpi in commercial pigs indicates that LEF1 is possibly
involved in the greater proliferation and fusion of myoblasts in this breed, which could
account for the greater number of primary fibers in commercial pigs. Indeed, as
mentioned above, LEF1 can induce cell cycle progression and cellular differentiation
(<xref rid="B54" ref-type="bibr">Zhou <italic>et al.</italic>, 2008</xref>).</p><p>
<italic>MRAS</italic> showed greater expression during the period of somite formation
and proliferation (21 dpi) and primary fiber formation (40 dpi), with lower expression
thereafter. This gene is related to the biological processes of muscle organ development
and organ development and is involved in the MAPK signaling pathway. MRAS is a negative
regulator of myoblast differentiation during myogenesis (<xref rid="B52" ref-type="bibr">Yokoyama <italic>et al.</italic>, 2007</xref>). Thus, we suggest that this gene has
a greater role at 21 and 40 dpi, possibly by controlling somite formation and
proliferation, as well as myoblast differentiation in primary fibers. MRAS can
negatively regulate the expression and function of muscle-specific transcription factors
such as <italic>MYOD</italic> and <italic>MEF2</italic> family (<xref rid="B19" ref-type="bibr">Lassar <italic>et al.</italic>, 1989</xref>; <xref rid="B49" ref-type="bibr">Winter and Arnold, 2000</xref>; <xref rid="B42" ref-type="bibr">Tortorella
<italic>et al.</italic>, 2001</xref>) that are essential for controlling myoblast
development and fusion to give rise to primary myotubes in both breeds. Myoblast
differentiation into myotubes thus involves a balance between genes that activate and
inhibit the process.</p><p>
<italic>CHD8, EID2B, HIF1AN, IKBKB, RSPO3, SOX7</italic> and <italic>SUFU</italic>
showed no changes in expression during the various periods or between breeds. Since
there were no changes in gene expression, studies at the protein level are necessary in
order to assess the roles of these genes in myogenesis in commercial and Piau pigs;
differences in the amount of activated protein could be an important factor in
distinguishing between the two breeds.</p><p>
<italic>CHD8, RSPO3, SOX7</italic> and <italic>SUFU</italic> are related to embryo
development. <italic>CHD8</italic> belongs to the WNT signaling pathway and can
negatively regulate the transcriptional activity of various genes induced by activation
of the WNT/&#x003b2;-catenin signaling pathway (<xref rid="B27" ref-type="bibr">Nishiyama
<italic>et al.</italic>, 2012</xref>), in addition to preventing apoptosis (<xref rid="B26" ref-type="bibr">Nishiyama <italic>et al.</italic>, 2009</xref>). RSPO3 is a
positive regulator of myogenesis in skeletal muscle by activating the WNT/&#x003b2;-catenin
signaling pathway and can induce <italic>MYF5</italic> expression (<xref rid="B11" ref-type="bibr">Han <italic>et al.</italic>, 2011</xref>). SOX7 is a negative regulator of
the WNT/&#x003b2;-catenin signaling pathway (<xref rid="B7" ref-type="bibr">Chan <italic>et
al.</italic>, 2012</xref>) and can also be a tumor suppressor (<xref rid="B40" ref-type="bibr">Takash <italic>et al.</italic>, 2001</xref>).
<italic>SUFU</italic> is related to the biological process of organ development and
is included in the Hedgehog signaling pathway, of which it is a negative regulator by
suppressing the activity and function of GLI transcription factors (<xref rid="B10" ref-type="bibr">Ding <italic>et al.</italic>, 1999</xref>). This
suppression can increase the expression of specific muscle genes such as
<italic>MYOD</italic> (<xref rid="B45" ref-type="bibr">Voronova <italic>et
al.</italic>, 2013</xref>). The pathway is important for myogenesis because it is
involved in cell proliferation and differentiation, tissue remodeling (<xref rid="B12" ref-type="bibr">Heretsch <italic>et al.</italic>, 2010</xref>), and
specifies cellular growth and differentiation patterns (<xref rid="B32" ref-type="bibr">Rossi <italic>et al.</italic>, 2007</xref>).</p><p>
<italic>EID2B</italic> and <italic>HIF1AN</italic> are involved in the biological
process muscle organ development. <italic>EID2B</italic> is also related to muscle
differentiation and can prevent myoblast differentiation into myotubes (<xref rid="B34" ref-type="bibr">Sasajima <italic>et al.</italic>, 2005</xref>).
<italic>HIF1AN</italic> is also involved in the biological process of muscle
structure development. This gene negatively regulates apoptosis (<xref rid="B51" ref-type="bibr">Yan <italic>et al.</italic>, 2011</xref>) and is important for myoblast
differentiation, in which it acts as a crucial transcription factor that regulates
myogenesis (<xref rid="B20" ref-type="bibr">Li <italic>et al.</italic>, 2007</xref>).
Unaltered <italic>HIF1AN</italic> mRNA expression has already been observed during
myogenesis (<xref rid="B46" ref-type="bibr">Wagatsuma <italic>et al.</italic>,
2011</xref>).</p><p>
<italic>IKBKB</italic> is included in the MAPK signaling pathway and is related to the
biological processes of skeletal muscle contraction, muscle system process and
musculoskeletal movement. This gene can negatively regulate myoblast differentiation
during myogenesis (<xref rid="B3" ref-type="bibr">Bakkar <italic>et al.</italic>,
2008</xref>).</p><p>Overall, the results of this study indicate that the <italic>LEF1</italic> gene is a
primary candidate to explain the difference in muscularity between commercial and Piau
pigs. Although this gene is expressed in both breeds, in commercial pigs this expression
probably leads to greater fusion of myoblasts than in Piau pigs. In commercial pigs,
<italic>LEF1</italic> showed an additional peak of greater expression at 40 dpi that
corresponds to a critical period of myoblast proliferation and fusion during the first
wave of myofiber formation. Thus, the greater number of fibers formed in commercial pigs
compared to Piau pigs accounts for the greater muscularity seen in the former breed
during postnatal development. The potential growth of skeletal muscle depends on the
number of muscle fibers formed during the prenatal period and their postnatal
hypertrophy (<xref rid="B31" ref-type="bibr">Rehfeldt <italic>et al.</italic>,
2000</xref>).</p><p>The findings reported here contribute to our understanding of the molecular mechanisms
involved in muscle tissue formation in a commercial pig breed (the three-way Duroc,
Landrace and Large-White cross) and Piau pigs. The new information on gene expression
analyzed by qRT-PCR for the first time in pigs should be useful in understanding
myogenesis and the possible mechanisms involved in the differences in muscularity
between genetically distinct breeds.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors thank the trainees and employees of the Swine Breeding Farm at Universidade
Federal de Vi&#x000e7;osa for help in sample collection. EPR was supported by a scholarship from
Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior(CAPES) and Conselho Nacional
de Desenvolvimento Cient&#x000ed;fico e Tecnol&#x000f3;gico (CNPq). This work was supported by grants
from CNPq (472858/2010-6 and 478181/2012-4).</p></ack><fn-group><fn fn-type="other" id="fn1"><p>
<italic>Associate Editor: Alexandre Rodrigues Caetano</italic>
</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>CL</given-names></name><name><surname>Jensen</surname><given-names>JL</given-names></name><name><surname>Orntoft</surname><given-names>TF</given-names></name></person-group><year>2004</year><article-title>Normalization of real-time quantitative reverse transcription-PCR
data: A model-based variance estimation approach to identify genes suited for
normalization, applied to bladder and colon cancer data sets</article-title><source>Cancer Res</source><volume>64</volume><fpage>5245</fpage><lpage>5250</lpage><pub-id pub-id-type="pmid">15289330</pub-id></element-citation></ref><ref id="B2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arber</surname><given-names>S</given-names></name><name><surname>Halder</surname><given-names>G</given-names></name><name><surname>Caroni</surname><given-names>P</given-names></name></person-group><year>1994</year><article-title>Muscle LIM protein, a novel essential regulator of myogenesis,
promotes myogenic differentiation</article-title><source>Cell</source><volume>79</volume><fpage>221</fpage><lpage>231</lpage><pub-id pub-id-type="pmid">7954791</pub-id></element-citation></ref><ref id="B3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakkar</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Ladner</surname><given-names>KJ</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Dahlman</surname><given-names>JM</given-names></name><name><surname>Carathers</surname><given-names>M</given-names></name><name><surname>Acharyya</surname><given-names>S</given-names></name><name><surname>Rudnicki</surname><given-names>MA</given-names></name><name><surname>Hollenbach</surname><given-names>AD</given-names></name><name><surname>Guttridge</surname><given-names>DC</given-names></name></person-group><year>2008</year><article-title>IKK/NF-&#x003ba;&#x00392; regulates skeletal myogenesis via a signaling switch to
inhibit differentiation and promote mitochondrial biogenesis</article-title><source>J Cell Biol</source><volume>180</volume><fpage>787</fpage><lpage>802</lpage><pub-id pub-id-type="pmid">18299349</pub-id></element-citation></ref><ref id="B4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beermann</surname><given-names>DH</given-names></name><name><surname>Cassens</surname><given-names>RG</given-names></name><name><surname>Hausman</surname><given-names>GJ</given-names></name></person-group><year>1978</year><article-title>A second look at fiber type differentiation in porcine skeletal
muscle</article-title><source>J Anim Sci</source><volume>46</volume><fpage>125</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">640968</pub-id></element-citation></ref><ref id="B5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benson</surname><given-names>DA</given-names></name><name><surname>Cavanaugh</surname><given-names>M</given-names></name><name><surname>Clark</surname><given-names>K</given-names></name><name><surname>Karsch-Mizrachi</surname><given-names>I</given-names></name><name><surname>Lipman</surname><given-names>DJ</given-names></name><name><surname>Ostell</surname><given-names>J</given-names></name><name><surname>Sayers</surname><given-names>EW</given-names></name></person-group><year>2013</year><article-title>GenBank</article-title><source>Nucleic Acids Res</source><volume>41</volume><fpage>D36</fpage><lpage>D42</lpage><pub-id pub-id-type="pmid">23193287</pub-id></element-citation></ref><ref id="B6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cagnazzo</surname><given-names>M</given-names></name><name><surname>te Pas</surname><given-names>MF</given-names></name><name><surname>Priem</surname><given-names>J</given-names></name><name><surname>de Wit</surname><given-names>AA</given-names></name><name><surname>Pool</surname><given-names>MH</given-names></name><name><surname>Davoli</surname><given-names>R</given-names></name><name><surname>Russo</surname><given-names>V</given-names></name></person-group><year>2006</year><article-title>Comparison of prenatal muscle tissue expression profiles of two pig
breeds differing in muscle characteristics</article-title><source>J Anim Sci</source><volume>84</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">16361485</pub-id></element-citation></ref><ref id="B7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>DW</given-names></name><name><surname>Mak</surname><given-names>CS</given-names></name><name><surname>Leung</surname><given-names>TH</given-names></name><name><surname>Chan</surname><given-names>KK</given-names></name><name><surname>Ngan</surname><given-names>HY</given-names></name></person-group><year>2012</year><article-title>Down-regulation of Sox7 is associated with aberrant activation of
Wnt/b-catenin signaling in endometrial cancer</article-title><source>Oncotarget</source><volume>3</volume><fpage>1546</fpage><lpage>1556</lpage><pub-id pub-id-type="pmid">23295859</pub-id></element-citation></ref><ref id="B8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cossu</surname><given-names>G</given-names></name><name><surname>Borello</surname><given-names>U</given-names></name></person-group><year>1999</year><article-title>Wnt signaling and the activation of myogenesis in
mammals</article-title><source>EMBO J</source><volume>18</volume><fpage>6867</fpage><lpage>6872</lpage><pub-id pub-id-type="pmid">10601008</pub-id></element-citation></ref><ref id="B9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dennis</surname><given-names>G</given-names><suffix>Jr</suffix></name><name><surname>Sherman</surname><given-names>BT</given-names></name><name><surname>Hosack</surname><given-names>DA</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Lane</surname><given-names>HC</given-names></name><name><surname>Lempicki</surname><given-names>RA</given-names></name></person-group><year>2003</year><article-title>DAVID: Database for annotation, visualization, and integrated
discovery</article-title><source>Genome Biol</source><volume>4</volume><fpage>P3</fpage><lpage>P3</lpage><pub-id pub-id-type="pmid">12734009</pub-id></element-citation></ref><ref id="B10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>Q</given-names></name><name><surname>Fukami</surname><given-names>S</given-names></name><name><surname>Meng</surname><given-names>X</given-names></name><name><surname>Nishizaki</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Sasaki</surname><given-names>H</given-names></name><name><surname>Dlugosz</surname><given-names>A</given-names></name><name><surname>Nakafuku</surname><given-names>M</given-names></name><name><surname>Hui</surname><given-names>C</given-names></name></person-group><year>1999</year><article-title>Mouse suppressor of fused is a negative regulator of sonic hedgehog
signaling and alters the subcellular distribution of Gli1</article-title><source>Curr Biol</source><volume>9</volume><fpage>1119</fpage><lpage>1122</lpage><pub-id pub-id-type="pmid">10531011</pub-id></element-citation></ref><ref id="B11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>XH</given-names></name><name><surname>Jin</surname><given-names>YR</given-names></name><name><surname>Seto</surname><given-names>M</given-names></name><name><surname>Yoon</surname><given-names>JK</given-names></name></person-group><year>2011</year><article-title>A WNT/&#x003b2;-catenin signaling activator, R-spondin, plays positive
regulatory roles during skeletal myogenesis</article-title><source>J Biol Chem</source><volume>286</volume><fpage>10649</fpage><lpage>10659</lpage><pub-id pub-id-type="pmid">21252233</pub-id></element-citation></ref><ref id="B12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heretsch</surname><given-names>P</given-names></name><name><surname>Tzagkaroulaki</surname><given-names>L</given-names></name><name><surname>Giannis</surname><given-names>A</given-names></name></person-group><year>2010</year><article-title>Modulators of the hedgehog signaling pathway</article-title><source>Bioorg Med Chem</source><volume>18</volume><fpage>6613</fpage><lpage>6624</lpage><pub-id pub-id-type="pmid">20708941</pub-id></element-citation></ref><ref id="B13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Sherman</surname><given-names>BT</given-names></name><name><surname>Lempicki</surname><given-names>RA</given-names></name></person-group><year>2009</year><article-title>Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources</article-title><source>Nat Protoc</source><volume>4</volume><fpage>44</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">19131956</pub-id></element-citation></ref><ref id="B14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>D</given-names></name><name><surname>Hidaka</surname><given-names>K</given-names></name><name><surname>Shirai</surname><given-names>M</given-names></name><name><surname>Morisaki</surname><given-names>T</given-names></name></person-group><year>2010</year><article-title>RNA-binding motif protein 24 regulates myogenin expression and
promotes myogenic differentiation</article-title><source>Genes Cells</source><volume>15</volume><fpage>1158</fpage><lpage>1167</lpage><pub-id pub-id-type="pmid">20977548</pub-id></element-citation></ref><ref id="B15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jo</surname><given-names>C</given-names></name><name><surname>Jang</surname><given-names>BG</given-names></name><name><surname>Jo</surname><given-names>SA</given-names></name></person-group><year>2009</year><article-title>MEK1 plays contrary stage-specific roles in skeletal myogenic
differentiation</article-title><source>Cell Signal</source><volume>21</volume><fpage>1910</fpage><lpage>1917</lpage><pub-id pub-id-type="pmid">19733237</pub-id></element-citation></ref><ref id="B16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaimal</surname><given-names>V</given-names></name><name><surname>Bardes</surname><given-names>EE</given-names></name><name><surname>Tabar</surname><given-names>SC</given-names></name><name><surname>Jegga</surname><given-names>AG</given-names></name><name><surname>Aronow</surname><given-names>BJ</given-names></name></person-group><year>2010</year><article-title>ToppCluster: A multiple gene list feature analyzer for comparative
enrichment clustering and network-based dissection of biological
systems</article-title><source>Nucleic Acids Res</source><volume>38</volume><fpage>W96</fpage><lpage>W102</lpage><pub-id pub-id-type="pmid">20484371</pub-id></element-citation></ref><ref id="B17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keren</surname><given-names>A</given-names></name><name><surname>Tamir</surname><given-names>Y</given-names></name><name><surname>Bengal</surname><given-names>E</given-names></name></person-group><year>2006</year><article-title>The p38 MAPK signaling pathway: A major regulator of skeletal muscle
development</article-title><source>Mol Cell Endocrinol</source><volume>252</volume><fpage>224</fpage><lpage>230</lpage><pub-id pub-id-type="pmid">16644098</pub-id></element-citation></ref><ref id="B18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>Y</given-names></name><name><surname>Flick</surname><given-names>MJ</given-names></name><name><surname>Kudla</surname><given-names>AJ</given-names></name><name><surname>Konieczny</surname><given-names>SF</given-names></name></person-group><year>1997</year><article-title>Muscle LIM protein promotes myogenesis by enhancing the activity of
MyoD</article-title><source>Mol Cell Biol</source><volume>17</volume><fpage>4750</fpage><lpage>4760</lpage><pub-id pub-id-type="pmid">9234731</pub-id></element-citation></ref><ref id="B19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lassar</surname><given-names>AB</given-names></name><name><surname>Thayer</surname><given-names>MJ</given-names></name><name><surname>Overell</surname><given-names>RW</given-names></name><name><surname>Weintraub</surname><given-names>H</given-names></name></person-group><year>1989</year><article-title>Transformation by activated ras or fos prevents myogenesis by
inhibiting expression of MyoD1</article-title><source>Cell</source><volume>58</volume><fpage>659</fpage><lpage>667</lpage><pub-id pub-id-type="pmid">2548731</pub-id></element-citation></ref><ref id="B20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Fan</surname><given-names>M</given-names></name></person-group><year>2007</year><article-title>Effects of hypoxia on proliferation and differentiation of
myoblasts</article-title><source>Med Hypotheses</source><volume>69</volume><fpage>629</fpage><lpage>636</lpage><pub-id pub-id-type="pmid">17395396</pub-id></element-citation></ref><ref id="B21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>KJ</given-names></name><name><surname>Schmittgen</surname><given-names>TD</given-names></name></person-group><year>2001</year><article-title>Analysis of relative gene expression data using real-time quantitative
PCR and the 2<sup>&#x02212;&#x00394;&#x00394;CT</sup> method</article-title><source>Methods</source><volume>25</volume><fpage>402</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">11846609</pub-id></element-citation></ref><ref id="B22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maltin</surname><given-names>CA</given-names></name><name><surname>Delday</surname><given-names>MI</given-names></name><name><surname>Sinclair</surname><given-names>KD</given-names></name><name><surname>Steven</surname><given-names>J</given-names></name><name><surname>Sneddon</surname><given-names>AA</given-names></name></person-group><year>2001</year><article-title>Impact of manipulations of myogenesis <italic>in utero</italic> on the
performance of adult skeletal muscle</article-title><source>Reproduction</source><volume>122</volume><fpage>359</fpage><lpage>374</lpage><pub-id pub-id-type="pmid">11597302</pub-id></element-citation></ref><ref id="B23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCulloch</surname><given-names>RS</given-names></name><name><surname>Ashwell</surname><given-names>MS</given-names></name><name><surname>O&#x02019;Nan</surname><given-names>AT</given-names></name><name><surname>Mente</surname><given-names>PL</given-names></name></person-group><year>2012</year><article-title>Identification of stable normalization genes for quantitative
real-time PCR in porcine articular cartilage</article-title><source>J Anim Sci Biotechnol</source><volume>3</volume><fpage>36</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">23146128</pub-id></element-citation></ref><ref id="B24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyamoto</surname><given-names>S</given-names></name><name><surname>Hidaka</surname><given-names>K</given-names></name><name><surname>Jin</surname><given-names>D</given-names></name><name><surname>Morisaki</surname><given-names>T</given-names></name></person-group><year>2009</year><article-title>RNA-binding proteins Rbm38 and Rbm24 regulate myogenic differentiation
via p21-dependent and -independent regulatory pathways</article-title><source>Genes Cells</source><volume>14</volume><fpage>1241</fpage><lpage>1252</lpage><pub-id pub-id-type="pmid">19817877</pub-id></element-citation></ref><ref id="B25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murani</surname><given-names>E</given-names></name><name><surname>Muraniova</surname><given-names>M</given-names></name><name><surname>Ponsuksili</surname><given-names>S</given-names></name><name><surname>Schellander</surname><given-names>K</given-names></name><name><surname>Wimmers</surname><given-names>K</given-names></name></person-group><year>2007</year><article-title>Identification of genes differentially expressed during prenatal
development of skeletal muscle in two pig breeds differing in
muscularity</article-title><source>BMC Dev Biol</source><volume>7</volume><elocation-id>e109</elocation-id></element-citation></ref><ref id="B26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishiyama</surname><given-names>M</given-names></name><name><surname>Oshikawa</surname><given-names>K</given-names></name><name><surname>Tsukada</surname><given-names>Y</given-names></name><name><surname>Nakagawa</surname><given-names>T</given-names></name><name><surname>Iemura</surname><given-names>S</given-names></name><name><surname>Natsume</surname><given-names>T</given-names></name><name><surname>Fan</surname><given-names>Y</given-names></name><name><surname>Kikuchi</surname><given-names>A</given-names></name><name><surname>Skoultchi</surname><given-names>AI</given-names></name><name><surname>Nakayama</surname><given-names>KI</given-names></name></person-group><year>2009</year><article-title>CHD8 suppresses p53-mediated apoptosis through histone H1 recruitment
during early embryogenesis</article-title><source>Nat Cell Biol</source><volume>11</volume><fpage>172</fpage><lpage>182</lpage><pub-id pub-id-type="pmid">19151705</pub-id></element-citation></ref><ref id="B27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishiyama</surname><given-names>M</given-names></name><name><surname>Skoultchi</surname><given-names>AI</given-names></name><name><surname>Nakayama</surname><given-names>KI</given-names></name></person-group><year>2012</year><article-title>Histone H1 recruitment by CHD8 is essential for suppression of the
Wnt-&#x003b2;-catenin signaling pathway</article-title><source>Mol Cell Biol</source><volume>32</volume><fpage>501</fpage><lpage>512</lpage><pub-id pub-id-type="pmid">22083958</pub-id></element-citation></ref><ref id="B28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owczarzy</surname><given-names>R</given-names></name><name><surname>Tataurov</surname><given-names>AV</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Manthey</surname><given-names>JA</given-names></name><name><surname>McQuisten</surname><given-names>KA</given-names></name><name><surname>Almabrazi</surname><given-names>HG</given-names></name><name><surname>Pedersen</surname><given-names>KF</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Garretson</surname><given-names>J</given-names></name><name><surname>McEntaggart</surname><given-names>NO</given-names></name><etal/></person-group><year>2008</year><article-title>IDT SciTools: A suite for analysis and design of nucleic acid
oligomers</article-title><source>Nucleic Acids Res</source><volume>36</volume><fpage>W163</fpage><lpage>W169</lpage><pub-id pub-id-type="pmid">18440976</pub-id></element-citation></ref><ref id="B29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>RL</given-names></name><name><surname>Parker</surname><given-names>MH</given-names></name><name><surname>Rudnicki</surname><given-names>MA</given-names></name></person-group><year>2001</year><article-title>Activated MEK1 binds the nuclear MyoD transcriptional complex to
repress transactivation</article-title><source>Mol Cell</source><volume>8</volume><fpage>291</fpage><lpage>301</lpage><pub-id pub-id-type="pmid">11545732</pub-id></element-citation></ref><ref id="B30"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rasmussen</surname><given-names>R</given-names></name></person-group><year>2001</year><chapter-title>Quantification on the lightcycler</chapter-title><person-group person-group-type="editor"><name><surname>Meuer</surname><given-names>S</given-names></name><name><surname>Wittwer</surname><given-names>C</given-names></name><name><surname>Nakagawara</surname><given-names>K</given-names></name></person-group><source>Rapid Cycle Real-Time PCR: Methods and Applications</source><publisher-name>Springer</publisher-name><publisher-loc>Heidelberg</publisher-loc><fpage>21</fpage><lpage>34</lpage></element-citation></ref><ref id="B31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rehfeldt</surname><given-names>C</given-names></name><name><surname>Fiedler</surname><given-names>I</given-names></name><name><surname>Dietl</surname><given-names>G</given-names></name><name><surname>Ender</surname><given-names>K</given-names></name></person-group><year>2000</year><article-title>Myogenesis and postnatal skeletal muscle cell growth as influenced by
selection</article-title><source>Livest Prod Sci</source><volume>66</volume><fpage>177</fpage><lpage>188</lpage></element-citation></ref><ref id="B32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>D</given-names></name><name><surname>Murayama</surname><given-names>T</given-names></name><name><surname>Manini</surname><given-names>I</given-names></name><name><surname>Franci</surname><given-names>D</given-names></name><name><surname>Ogawa</surname><given-names>Y</given-names></name><name><surname>Sorrentino</surname><given-names>V</given-names></name></person-group><year>2007</year><article-title>Expression and functional activity of ryanodine receptors (RyRs)
during skeletal muscle development</article-title><source>Cell Calcium</source><volume>41</volume><fpage>573</fpage><lpage>580</lpage><pub-id pub-id-type="pmid">17118445</pub-id></element-citation></ref><ref id="B33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Safran</surname><given-names>M</given-names></name><name><surname>Dalah</surname><given-names>I</given-names></name><name><surname>Alexander</surname><given-names>J</given-names></name><name><surname>Rosen</surname><given-names>N</given-names></name><name><surname>Iny Stein</surname><given-names>T</given-names></name><name><surname>Shmoish</surname><given-names>M</given-names></name><name><surname>Nativ</surname><given-names>N</given-names></name><name><surname>Bahir</surname><given-names>I</given-names></name><name><surname>Doniger</surname><given-names>T</given-names></name><name><surname>Krug</surname><given-names>H</given-names></name><etal/></person-group><year>2010</year><article-title>GeneCards Version 3: The human gene integrator</article-title><source>Database</source><comment>2010</comment><comment>baq020</comment></element-citation></ref><ref id="B34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasajima</surname><given-names>Y</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Miyake</surname><given-names>S</given-names></name><name><surname>Yuasa</surname><given-names>Y</given-names></name></person-group><year>2005</year><article-title>A novel EID family member, EID-3, inhibits differentiation and forms a
homodimer or heterodimer with EID-2</article-title><source>Biochem Biophys Res Commun</source><volume>333</volume><fpage>969</fpage><lpage>975</lpage><pub-id pub-id-type="pmid">15970276</pub-id></element-citation></ref><ref id="B35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ser&#x000e3;o</surname><given-names>NV</given-names></name><name><surname>Veroneze</surname><given-names>R</given-names></name><name><surname>Ribeiro</surname><given-names>AM</given-names></name><name><surname>Verardo</surname><given-names>LL</given-names></name><name><surname>Braccini</surname><given-names>J</given-names><suffix>Neto</suffix></name><name><surname>Gasparino</surname><given-names>E</given-names></name><name><surname>Campos</surname><given-names>CF</given-names></name><name><surname>Lopes</surname><given-names>PS</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>SE</given-names></name></person-group><year>2011</year><article-title>Candidate gene expression and intramuscular fat content in
pigs</article-title><source>J Anim Breed Genet</source><volume>128</volume><fpage>28</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">21214641</pub-id></element-citation></ref><ref id="B36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shannon</surname><given-names>P</given-names></name><name><surname>Markiel</surname><given-names>A</given-names></name><name><surname>Ozier</surname><given-names>O</given-names></name><name><surname>Baliga</surname><given-names>NS</given-names></name><name><surname>Wang</surname><given-names>JT</given-names></name><name><surname>Ramage</surname><given-names>D</given-names></name><name><surname>Amin</surname><given-names>N</given-names></name><name><surname>Schwikowski</surname><given-names>B</given-names></name><name><surname>Ideker</surname><given-names>T</given-names></name></person-group><year>2003</year><article-title>Cytoscape: A software environment for integrated models of
biomolecular interaction networks</article-title><source>Genome Res</source><volume>13</volume><fpage>2498</fpage><lpage>2504</lpage><pub-id pub-id-type="pmid">14597658</pub-id></element-citation></ref><ref id="B37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sollero</surname><given-names>BP</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>SE</given-names></name><name><surname>Rilington</surname><given-names>VD</given-names></name><name><surname>Tempelman</surname><given-names>RJ</given-names></name><name><surname>Raney</surname><given-names>NE</given-names></name><name><surname>Steibel</surname><given-names>JP</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>JD</given-names></name><name><surname>Lopes</surname><given-names>PS</given-names></name><name><surname>Lopes</surname><given-names>MS</given-names></name><name><surname>Ernst</surname><given-names>CW</given-names></name></person-group><year>2011</year><article-title>Transcriptional profiling during foetal skeletal muscle development of
Piau and Yorkshire-Landrace cross-bred pigs</article-title><source>Anim Genet</source><volume>42</volume><fpage>600</fpage><lpage>612</lpage><pub-id pub-id-type="pmid">22035001</pub-id></element-citation></ref><ref id="B38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steibel</surname><given-names>JP</given-names></name><name><surname>Poletto</surname><given-names>R</given-names></name><name><surname>Coussens</surname><given-names>PM</given-names></name><name><surname>Rosa</surname><given-names>GJ</given-names></name></person-group><year>2009</year><article-title>A powerful and flexible linear mixed model framework for the analysis
of relative quantification RT-PCR data</article-title><source>Genomics</source><volume>94</volume><fpage>146</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">19422910</pub-id></element-citation></ref><ref id="B39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swatland</surname><given-names>HJ</given-names></name><name><surname>Cassens</surname><given-names>RG</given-names></name></person-group><year>1973</year><article-title>Prenatal development, histochemistry and innervation of porcine
muscle</article-title><source>J Anim Sci</source><volume>36</volume><fpage>343</fpage><lpage>354</lpage><pub-id pub-id-type="pmid">4346986</pub-id></element-citation></ref><ref id="B40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takash</surname><given-names>W</given-names></name><name><surname>Ca&#x000f1;izares</surname><given-names>J</given-names></name><name><surname>Bonneaud</surname><given-names>N</given-names></name><name><surname>Poulat</surname><given-names>F</given-names></name><name><surname>Matt&#x000e9;i</surname><given-names>M-G</given-names></name><name><surname>Jay</surname><given-names>P</given-names></name><name><surname>Berta</surname><given-names>P</given-names></name></person-group><year>2001</year><article-title>SOX7 transcription factor: Sequence, chromosomal localisation,
expression, transactivation and interference with Wnt signalling</article-title><source>Nucleic Acids Res</source><volume>29</volume><fpage>4274</fpage><lpage>4283</lpage><pub-id pub-id-type="pmid">11691915</pub-id></element-citation></ref><ref id="B41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Te Pas</surname><given-names>MF</given-names></name><name><surname>De Wit</surname><given-names>AA</given-names></name><name><surname>Priem</surname><given-names>J</given-names></name><name><surname>Cagnazzo</surname><given-names>M</given-names></name><name><surname>Davoli</surname><given-names>R</given-names></name><name><surname>Russo</surname><given-names>V</given-names></name><name><surname>Pool</surname><given-names>MH</given-names></name></person-group><year>2005</year><article-title>Transcriptome expression profiles in prenatal pigs in relation to
myogenesis</article-title><source>J Muscle Res Cell Motil</source><volume>26</volume><fpage>157</fpage><lpage>165</lpage><pub-id pub-id-type="pmid">15999225</pub-id></element-citation></ref><ref id="B42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tortorella</surname><given-names>LL</given-names></name><name><surname>Milasincic</surname><given-names>DJ</given-names></name><name><surname>Pilch</surname><given-names>PF</given-names></name></person-group><year>2001</year><article-title>Critical proliferation-independent window for basic fibroblast growth
factor repression of myogenesis via the p42/p44 MAPK signaling
pathway</article-title><source>J Biol Chem</source><volume>276</volume><fpage>13709</fpage><lpage>13717</lpage><pub-id pub-id-type="pmid">11279003</pub-id></element-citation></ref><ref id="B43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulloa</surname><given-names>F</given-names></name><name><surname>Itasaki</surname><given-names>N</given-names></name><name><surname>Briscoe</surname><given-names>J</given-names></name></person-group><year>2007</year><article-title>Inhibitory Gli3 activity negatively regulates Wnt/ &#x003b2;-catenin
signaling</article-title><source>Curr Biol</source><volume>17</volume><fpage>545</fpage><lpage>550</lpage><pub-id pub-id-type="pmid">17331723</pub-id></element-citation></ref><ref id="B44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Maltzahn</surname><given-names>J</given-names></name><name><surname>Chang</surname><given-names>NC</given-names></name><name><surname>Bentzinger</surname><given-names>CF</given-names></name><name><surname>Rudnicki</surname><given-names>MA</given-names></name></person-group><year>2012</year><article-title>Wnt signaling in myogenesis</article-title><source>Trends Cell Biol</source><volume>22</volume><fpage>602</fpage><lpage>609</lpage><pub-id pub-id-type="pmid">22944199</pub-id></element-citation></ref><ref id="B45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voronova</surname><given-names>A</given-names></name><name><surname>Coyne</surname><given-names>E</given-names></name><name><surname>Al Madhoun</surname><given-names>A</given-names></name><name><surname>Fair</surname><given-names>JV</given-names></name><name><surname>Bosiljcic</surname><given-names>N</given-names></name><name><surname>St-Louis</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Thurig</surname><given-names>S</given-names></name><name><surname>Wallace</surname><given-names>VA</given-names></name><name><surname>Wiper-Bergeron</surname><given-names>N</given-names></name><etal/></person-group><year>2013</year><article-title>Hedgehog signaling regulates MyoD expression and
activity</article-title><source>J Biol Chem</source><volume>288</volume><fpage>4389</fpage><lpage>4404</lpage><pub-id pub-id-type="pmid">23266826</pub-id></element-citation></ref><ref id="B46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagatsuma</surname><given-names>A</given-names></name><name><surname>Kotake</surname><given-names>N</given-names></name><name><surname>Yamada</surname><given-names>S</given-names></name></person-group><year>2011</year><article-title>Spatial and temporal expression of hypoxia-inducible factor-1&#x003b1; during
myogenesis <italic>in vivo</italic> and <italic>in vitro</italic>
</article-title><source>Mol Cell Biochem</source><volume>347</volume><fpage>145</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">20957412</pub-id></element-citation></ref><ref id="B47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wigmore</surname><given-names>PM</given-names></name><name><surname>Evans</surname><given-names>DJ</given-names></name></person-group><year>2002</year><article-title>Molecular and cellular mechanisms involved in the generation of fiber
diversity during myogenesis</article-title><source>Int Rev Cytol</source><volume>216</volume><fpage>175</fpage><lpage>232</lpage><pub-id pub-id-type="pmid">12049208</pub-id></element-citation></ref><ref id="B48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wigmore</surname><given-names>PM</given-names></name><name><surname>Stickland</surname><given-names>NC</given-names></name></person-group><year>1983</year><article-title>Muscle development in large and small pig fetuses</article-title><source>J Anat</source><volume>137</volume><fpage>235</fpage><lpage>245</lpage><pub-id pub-id-type="pmid">6630038</pub-id></element-citation></ref><ref id="B49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winter</surname><given-names>B</given-names></name><name><surname>Arnold</surname><given-names>HH</given-names></name></person-group><year>2000</year><article-title>Activated raf kinase inhibits muscle cell differentiation through a
MEF2-dependent mechanism</article-title><source>J Cell Sci</source><volume>113</volume><fpage>4211</fpage><lpage>4220</lpage><pub-id pub-id-type="pmid">11069766</pub-id></element-citation></ref><ref id="B50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Woodring</surname><given-names>PJ</given-names></name><name><surname>Bhakta</surname><given-names>KS</given-names></name><name><surname>Tamura</surname><given-names>K</given-names></name><name><surname>Wen</surname><given-names>F</given-names></name><name><surname>Feramisco</surname><given-names>JR</given-names></name><name><surname>Karin</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>JYJ</given-names></name><name><surname>Puri</surname><given-names>PL</given-names></name></person-group><year>2000</year><article-title>p38 and extracellular signal-regulated kinases regulate the myogenic
program at multiple steps</article-title><source>Mol Cell Biol</source><volume>20</volume><fpage>3951</fpage><lpage>3964</lpage><pub-id pub-id-type="pmid">10805738</pub-id></element-citation></ref><ref id="B51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>B</given-names></name><name><surname>Kong</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>YH</given-names></name></person-group><year>2011</year><article-title>Prevention of apoptosis by the interaction between FIH1 and
Bax</article-title><source>Mol Cell Biochem</source><volume>348</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">21069436</pub-id></element-citation></ref><ref id="B52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokoyama</surname><given-names>T</given-names></name><name><surname>Takano</surname><given-names>K</given-names></name><name><surname>Yoshida</surname><given-names>A</given-names></name><name><surname>Katada</surname><given-names>F</given-names></name><name><surname>Sun</surname><given-names>P</given-names></name><name><surname>Takenawa</surname><given-names>T</given-names></name><name><surname>Andoh</surname><given-names>T</given-names></name><name><surname>Endo</surname><given-names>T</given-names></name></person-group><year>2007</year><article-title>DA-Raf1, a competent intrinsic dominant-negative antagonist of the
Ras-ERK pathway, is required for myogenic differentiation</article-title><source>J Cell Biol</source><volume>177</volume><fpage>781</fpage><lpage>793</lpage><pub-id pub-id-type="pmid">17535970</pub-id></element-citation></ref><ref id="B53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Mo</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>A</given-names></name><name><surname>Gong</surname><given-names>W</given-names></name><name><surname>Xiao</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Qin</surname><given-names>L</given-names></name><name><surname>Niu</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><etal/></person-group><year>2011</year><article-title>Comparative analyses by sequencing of transcriptomes during skeletal
muscle development between pig breeds differing in muscle growth rate and
fatness</article-title><source>PLoS One</source><volume>6</volume><elocation-id>e19774</elocation-id><pub-id pub-id-type="pmid">21637832</pub-id></element-citation></ref><ref id="B54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Gong</surname><given-names>K</given-names></name><name><surname>Lu</surname><given-names>G</given-names></name><name><surname>Sheng</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Zhao</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Gong</surname><given-names>Y</given-names></name></person-group><year>2008</year><article-title>LEF-1 activates the transcription of E2F1</article-title><source>Biochem Biophys Res Commun</source><volume>365</volume><fpage>149</fpage><lpage>153</lpage><pub-id pub-id-type="pmid">17980157</pub-id></element-citation></ref></ref-list><ref-list><title>Internet resources</title><ref id="B55"><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>DAVID</collab></person-group><comment><ext-link ext-link-type="uri" xlink:href="http://david.abcc.ncifcrf.gov/tools.jsp">http://david.abcc.ncifcrf.gov/tools.jsp</ext-link></comment><month>2</month><day>02</day><year>2015</year></element-citation></ref><ref id="B56"><element-citation publication-type="database"><person-group person-group-type="author"><collab>BIOMART/ ENSEMBL</collab></person-group><comment><ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org/biomart/martview/">http://www.ensembl.org/biomart/martview/</ext-link></comment><month>2</month><day>02</day><year>2015</year></element-citation></ref><ref id="B57"><element-citation publication-type="database"><person-group person-group-type="author"><collab>GenBank</collab></person-group><comment><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/genbank/">https://www.ncbi.nlm.nih.gov/genbank/</ext-link></comment><month>2</month><day>02</day><year>2015</year></element-citation></ref><ref id="B58"><element-citation publication-type="database"><person-group person-group-type="author"><collab>Gene Cards Database</collab></person-group><comment><ext-link ext-link-type="uri" xlink:href="http://www.genecards.org/">http://www.genecards.org/</ext-link></comment><month>2</month><day>02</day><year>2015</year></element-citation></ref><ref id="B59"><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>PrimerQuest</collab></person-group><comment><ext-link ext-link-type="uri" xlink:href="http://www.idtdna.com/Primerquest/Home/Index">http://www.idtdna.com/Primerquest/Home/Index</ext-link></comment><month>2</month><day>02</day><year>2015</year></element-citation></ref><ref id="B60"><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Normfinder</collab></person-group><comment><ext-link ext-link-type="uri" xlink:href="http://moma.dk/normfinder-software">http://moma.dk/normfinder-software</ext-link></comment><month>2</month><day>02</day><year>2015</year></element-citation></ref><ref id="B61"><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>%QPCR_MIXED</collab></person-group><comment><ext-link ext-link-type="uri" xlink:href="https://www.msu.edu/~steibelj/JP_files/QPCR.html">https://www.msu.edu/~steibelj/JP_files/QPCR.html</ext-link></comment><month>2</month><day>02</day><year>2015</year></element-citation></ref><ref id="B62"><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Toppcluster</collab></person-group><comment><ext-link ext-link-type="uri" xlink:href="https://toppcluster.cchmc.org">https://toppcluster.cchmc.org</ext-link></comment><month>2</month><day>02</day><year>2015</year></element-citation></ref></ref-list><app-group><app id="app1"><title>Supplementary material</title><p>The following online material is available for this article:</p><p>
<supplementary-material content-type="local-data" id="suppl1"><label>Table S1</label><caption><title> - Amplification efficiency for target and reference genes.</title></caption><media xlink:href="1415-4757-gmb-1678-4685-GMB-2015-0295-Suppl01.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material>
</p></app></app-group></back></article>